Literature DB >> 11555104

Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders.

T Suzuki1, K Yamauchi, T Kuwata, N Hayashi.   

Abstract

AIM: To study the mechanisms of hepatitis B vaccine non-response, we examined hepatitis B virus surface antigen (HBsAg)-induced proliferation of peripheral blood mononuclear cells (PBMC) obtained from hepatitis B (HB) vaccinees.
METHODS: Subsequently, we have examined the features of HBsAg-reactive CD4+ T cells in HB vaccine non-responders (NR). Based on serum antibodies to HBsAg (anti-HBs) titers, we divided these vaccinees into three groups: high responder (HR), middle responder (MR) and non-responder (NR), and examined HBsAg-induced proliferation of their PBMC.
RESULTS: We found that the in vitro response of PBMC to stimulation with HBsAg was correlated with their serum anti-HBs titer (mean stimulation index was 10.71 in HR, 4.37 in MR and 1.96 in NR). However, by the deletion of CD8+ T cells, the increased response was observed in two of four NRs.
CONCLUSIONS: The present results have also shown that at least four distinct HBsAg-reactive CD4+ clones existed (variable gene of T cell receptor beta (V beta) 17 + clone restricted with HLA-DR locus (DR4), V beta 8 + clone restricted with HLA-DQ locust (DQ7), and both V beta 5.1 + clone and V beta 20 + clone restricted with either DR9 or DQ3) in NRs. The results demonstrated that heterogeneous HBsAg-reactive CD4 clones existed in some HB vaccine NRs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555104     DOI: 10.1046/j.1440-1746.2001.02530.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

Authors:  D D Anthony; T Umbleja; J A Aberg; M Kang; K Medvik; M M Lederman; M G Peters; M J Koziel; E T Overton
Journal:  Vaccine       Date:  2011-03-11       Impact factor: 3.641

2.  Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.

Authors:  Hai-Jie Yang; Min Chen; Tong Cheng; Shui-Zhen He; Shao-Wei Li; Bao-Quan Guan; Zi-Heng Zhu; Ying Gu; Jun Zhang; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  Effect of Hejie decoction on T cell immune state of chronic hepatitis B patients.

Authors:  Shi-Jun Zhang; Ze-Xiong Chen; Shao-Xian Lao; Bi-Jun Huang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

Review 4.  Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Authors:  Alicia C Marín; Javier P Gisbert; María Chaparro
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.